跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Raphibon - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Raphibon
Approved
STANDARD
Raphibon
Azarias Pharmaceutical Laboratories Inc.,
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4ee352c2f857d1f9
Company
Azarias Pharmaceutical Laboratories Inc.,
Type
Standard
Approval Details
Approval Id
4ee352c2f857d1f9
Drug Approval Philippines Name
Raphibon
Product Name
Raphibon
Registration Number
DRP-11072
Brand Name
Raphibon
Generic Name
Multivitamins
Dosage Form
Film-Coated Tablet
Dosage Strength
Formulation: Each film-coated tablet contains: Ascorbic Acid (Vitamin C)-500mg Thiamine Mononitrate (Vitamin B1)-50mg Niacinamide (Vitamin B1)-50mg Riboflavin (Vitamin B2)-20mg Calcium Pantothenate-20mg Pyridoxine Hydrochloride (Vitamin B6)-5mg Cyanocobalamin (Vitamin B12)-5mcg
Manufacturer
Azarias Pharmaceutical Laboratories Inc.,
Trader
St. Raphael Archangel Pharmaceutical Product Distribution
Issuance Date
24 January 2022
Expiry Date
24 January 2027
Pharmacologic Category
Vitamins
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4ee352c2f857d1f9
Type
Standard
Back to Philippines FDA Approvals